The Kolling Institute is the longest-running medical research institute in New South Wales, holding a key role in research activities for over 100 years. It is jointly managed by the Northern Sydney Local Health District and the University of Sydney.
Within the NSLHD, the main precinct comprises Royal North Shore Hospital, a major public hospital, alongside the North Shore Private Hospital and the North Shore Health Hub, which houses major private healthcare providers such as Ramsay Health and GenesisCare.
Sangui Bio benefits from being part of this high-volume tertiary clinical network. Access to quality research facilities, an efficient ethics and regulatory infrastructure, low resource burden for companies, and rapid regulatory approvals together provide a distinctive advantage for clinical biomarker development.
